REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 72 filers reported holding REPARE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $274,059 | -79.9% | 22,687 | -82.4% | 0.00% | -100.0% |
| Q2 2023 | $1,366,386 | +32202.3% | 129,148 | -70.0% | 0.00% | -50.0% |
| Q1 2023 | $4,230 | -57.6% | 429,870 | -36.6% | 0.00% | -66.7% |
| Q4 2022 | $9,970 | -99.7% | 677,787 | +174.1% | 0.01% | +200.0% |
| Q3 2022 | $3,000,000 | +72.6% | 247,321 | +99.1% | 0.00% | +100.0% |
| Q2 2022 | $1,738,000 | -44.6% | 124,195 | -43.6% | 0.00% | -50.0% |
| Q1 2022 | $3,135,000 | -55.1% | 220,154 | -33.5% | 0.00% | -50.0% |
| Q4 2021 | $6,977,000 | +55.1% | 330,826 | +92.9% | 0.00% | +33.3% |
| Q3 2021 | $4,499,000 | +539.1% | 171,461 | +659.2% | 0.00% | – |
| Q2 2021 | $704,000 | -78.4% | 22,585 | -76.2% | 0.00% | -100.0% |
| Q4 2020 | $3,259,000 | -44.1% | 95,018 | -49.9% | 0.00% | -71.4% |
| Q3 2020 | $5,835,000 | -15.7% | 189,645 | -15.1% | 0.01% | -22.2% |
| Q2 2020 | $6,925,000 | – | 223,244 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $22,067,538 | 9.20% |
| CHI Advisors LLC | 2,997,939 | $29,499,719 | 7.83% |
| MPM BioImpact LLC | 1,639,849 | $16,136,114 | 4.19% |
| BVF INC/IL | 8,291,988 | $81,593,162 | 2.98% |
| HighVista Strategies LLC | 164,890 | $1,622,518 | 1.32% |
| Sio Capital Management, LLC | 228,538 | $2,248,814 | 1.11% |
| Deep Track Capital, LP | 2,727,606 | $26,839,643 | 1.10% |
| Redmile Group, LLC | 2,533,050 | $24,925,212 | 1.08% |
| Orbimed Advisors | 3,322,488 | $32,693,282 | 0.64% |
| Artal Group S.A. | 700,000 | $6,888 | 0.41% |